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Abstract 0 The stability of peptide DNA condensates was examined
after introducing glutaraldehyde to cross-link surface amine groups.
A 20 amino acid peptide (CWK18) was used to condense DNA into
small (70 nm) condensates. The reaction between glutaraldehyde and
peptide DNA condensates was indirectly monitored using a fluorescence-
based assay to establish reaction completion in 4−5 h when using
glutaraldehyde-to-peptide ratios of 1 to 4 mol equiv. Higher levels of
glutaraldehyde cross-linking led to significant increases in particle size.
The improved stability imparted by glutaraldehyde cross-linking was
demonstrated by the increased resistance of DNA condensates to
shear stress induced fragmentation. The cross-linked condensates
were also significantly more resistant to in vitro metabolism by serum
endonucleases. A decrease in the magnitude of transient gene
expression was determined for cross-linked DNA condensates which
also resulted in a 10-day steady-state expression when cross-linking
with 4 mol equiv of glutaraldehyde. The results suggest that cross-
linking DNA condensates may provide a means to alter the time course
of transient gene expression by inhibiting DNA metabolism.
Introduction
To achieve optimal and prolonged gene expression,
carrier molecules are used to protect plasmid DNA from
metabolism while en route, and once inside the target cell.
Strategies to enhance nonviral DNA delivery have focused
on the use of cationic carriers such as lipids, peptides, and
polymers that bind DNA through ionic interaction.1-5 In
each case, ion pairing leads to varying degrees of DNA
condensation, resulting in cationic particles that internalize
into cells and mediate transient gene expression.6
To be effective in delivering DNA, carrier molecules must
have low toxicity, exhibit low levels of antigenicity or
complement activation, and protect DNA from degrada-
tion.7 Simultaneously addressing each of these has been
one of the major impediments to developing highly effective
in vivo gene delivery formulations.1,8
The stability of DNA condensates in serum is dependent
on the nature and affinity of a carrier molecule for binding
DNA, the ionic strength, the concentration of endonuclease,
and the presence of molecules that compete for carrier
binding. Dissociation of the carrier molecule in serum
exposes DNA to metabolizing endonuclease leading to
premature degradation.9
Only a few studies have addressed the issue of DNA
metabolism despite its obvious relationship to the level and
duration of gene expression.9-13 Early studies by Wu and
co-workers concluded that high molecular weight (HMW)
polylysines could protect DNA from rapid metabolism in
vitro for up to 1.5 h.13 Subsequent studies by our group
determined that a 20 amino acid peptide (CWK18) was
sufficient to stabilize DNA condensates from in vitro
metabolism.14 Despite the ability of HMW polylysines to
retard metabolism, the associated toxicity of these polymers
has prompted the search for LMW carriers for use in vivo.15
An alternative strategy to achieve high affinity using
LMW carriers is to provide temporary stability through
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molecular cross-linking of carriers on DNA condensates.
The unpaired amines on the surface of peptide DNA
condensates could potentially be cross-linked with a variety
of agents.
Glutaraldehyde is a five-carbon dialdehyde which has
long been used as a reagent to increase the tensile strength
of transplanted pig heart valves and develop controlled
release microspheres for drug delivery.16-18 The chemical
cross-linking of albumin lysines with glutaraldehyde leads
to particles which have controlled drug release proper-
ties.19,20 The degree of cross-linking directly affects the
particle size, biodegradation, and release properties of
drugs encapsulated in glutaraldehyde cross-linked micro-
spheres.17,18,21
In the present study, we report the use of glutaraldehyde
to cross-link DNA condensates in an attempt to improve
their metabolic stability and alter the resulting transient
gene expression profiles in vitro. The results indicate that
cross-linking can be used to enhance the stability of LMW
peptide DNA condensates and leads to steady-state tran-
sient gene expression. These attributes may allow the
design of nonviral gene delivery carriers that mediate
prolonged transient gene expression in vivo.
Materials and Methods
CWK18 (alkylated Cys-Trp-Lys18) and dimeric CWK18 were
synthesized and characterized as described previously.22 Glut-
araldehyde, SDS, ethidium bromide, proteinase K, DNase I (EC
3.1.21.1) from bovine pancreas, and polylysine99, polylysine476, and
polylysine1007 were obtained from Sigma. pSEAP (plasmid secreted
alkaline phosphatase with SV40 promoter and late polyadenyla-
tion sequence) and SEAP chemiluminescent detection kit were
obtained from Clontech. pSEAP was grown in Escherichia coli and
purified using a Qiagen miniprep column (Valencia, CA). TPCK-
treated trypsin was obtained from Worthington Biochemicals
(Freehold, NJ). Bradford protein assay was obtained from BioRad
(Hercules, CA). MEM, fetal calf serum and electrophoresis grade
agarose were obtained from Gibco BRL (Gaithersburg, MD).
SYBR-Gold was obtained from Molecular Probes (Eugene, OR).
Preparation and Characterization of Cross-Linked DNA
CondensatessCWK18 DNA condensates were formed by adding
10 µg (100 µL) of pSEAP (4.7 kBp) to 3 nmol of CWK18 in 100 µL
of 5 mM HEPES, pH 7.4, while vortexing to prepare DNA
condensates possessing a calculated charge ratio (amine:phos-
phate) of 2:1. HMW polylysines99-1007 were prepared at 10 mg/
mL in HEPES and used to form DNA condensates at a 2:1 amine:
phosphate ratio for each.
After 30 min, CWK18 DNA condensates were reacted with either
3, 6, 9, or 12 nmol of glutaraldehyde (1 nmol/µL) for 12 h at 4 °C
resulting in 1, 2, 3, or 4 mol equiv (mol of glutaraldehyde per mol
of CWK18) of cross-linking. The reaction of glutaraldehyde with
DNA condensates was studied using a fluorophore exclusion assay.
Following the addition of glutaraldehyde, 10 µL aliquots were
removed at time intervals ranging from 0 to 5 h and immediately
combined with 490 µL of 0.35 M sodium chloride. Prior to
measuring fluorescence, 10 µL of SYBR-Gold (diluted 1:200 in
DMSO) was added, and the fluorescence intensity (Ex: 495 nm,
Em: 537 nm) was measured on a Perkin-Elmer LS-50B fluorim-
eter.
The particle size of cross-linked DNA condensates was mea-
sured using 350 µL of 50 µg/mL DNA condensate in HEPES by
quasielastic light scattering (QELS). ú potential measurements
were conducted at the same DNA concentration in HEPES using
an average of 10 runs to determine the mean and standard
deviation on a Brookhaven ZetaPlus.
Shear Stress Stability of DNA CondensatessPeptide DNA
condensates (200 µL) were combined with 0-90 µL of 5 M sodium
chloride and normalized with HEPES to a final volume of 300 µL
to obtain a final concentration of 0, 0.1, 0.3, 0.5, 0.7, 0.9, 1.2, or
1.5 M sodium chloride. A 100 W Microson XL-2000 ultrasonic
Figure 1sGlutaraldehyde cross-linking DNA condensates. CWK18 binds to plasmid DNA to spontaneously form condensed DNA possessing residual surface
amines. Glutaraldehdye is reacted with condensed DNA resulting in the formation of two Schiff-bases between neighboring amine groups resulting in cross-linked
DNA condensates. The degree of cross-linking is expressed as the mols of glutaraldehyde added relative to mols of CWK18.
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probe homogenizer (Kontes, Vineland, NJ) set at a vibrational
amplitude of 5 was used throughout the study. The probe tip was
placed 3/4 depth into a 1.5 mL microfuge tube containing 300 µL
of sample and then sonicated for 30 s. DNA samples (15 µL) were
brought to 1 M sodium chloride by adding 4.6 µL of 5 M sodium
chloride and then digested with trypsin (3 µL containing 7 U) for
12 h at 37 °C. The samples were combined with 3 µL of loading
buffer, and 18 µL was applied to a 1% agarose gel (50 mL)
containing 0.5 µg/mL ethidium bromide. The gel was electrophore-
sed in TAE buffer at 70 V for 80 min followed by 12 h destaining
in deionized water. Transilluminated gels were photographed on
polaroid 667 film.
Serum Stability of DNA CondensatessDNA condensates
(100 µL) were combined with 100 µL of DNase I augmented mouse
serum (0.12 U of DNase I per 100 µL serum) and 3 µL of 5 M
sodium chloride to bring the final salt concentration to 150 mM.
Samples were incubated at 37 °C for 3 h while withdrawing 20
µL aliquots that were rapidly frozen at time points ranging from
0 to 180 min. Serum samples were processed by adding 3 µL (0.31
U) of proteinase K and then incubated at 37 °C for 30 min to
remove endonuclease activity. Sodium chloride was then added
(4.6 µL of 5 M) along with trypsin (3 µL containing 7 U) and
allowed to digest for 12 h at 37 °C to remove the cross-linked
peptide. Samples were applied to a 1% agarose gel containing
0.05% SDS and electrophoresed as described above.
Transient Gene ExpressionsHepG2 cells (3 × 105) were
plated on 6 × 35 mm wells and grown for 48 h to 40% confluence
in MEM supplemented with 10% fetal calf serum (FCS). Cross-
linked DNA condensates (10 µg of DNA in 200 µL) were transfected
in triplicate by dropwise addition to cells in 10% FCS either with
or without 80 µM chloroquine followed by 5 h incubation, after
which the media was replaced with 2 mL of MEM containing 10%
fetal calf serum and allowed to incubate for an additional 19 h.
Wells were sampled for 10-days at 24 h intervals by removing and
freezing (-20 °C) the media and replacing it with 2 mL of fresh
10% FCS MEM. The amount of heat-stable SEAP in each well
was determined using a chemiluminescent kit. Media (50 µL) was
combined with 50 µL of dilution buffer followed by incubation at
65 °C for 30 min to denature endogenous alkaline phosphatase.
Assay buffer (100 µL) was added and incubated for 10 min at 25
°C followed by the addition of CSPD [(disodium 3-(4-methoxyspiro-
{1,2-dioxetane-3,2′-(5′-chloro) tricyclo [3.3.1.13,7] decan}-4-yl) phen-
yl phosphate)] substrate in chemiluminescent enhancer. After 30
min, the luminescence was measured with a 10 s integration on a
Berthold Lumat LB 9501 luminometer. Light units were converted
to µg/mL of SEAP using a standard curve constructed by adding
known quantities of SEAP to cell homogenate. Residual endo-
genous alkaline phosphatase background was determined from a
10-day null control and subtracted from each data set.
Results
The metabolic stability and transient gene expression
was investigated in relationship to the degree of cross-
linking applied to peptide DNA condensates. Peptide DNA
condensates are colloids that possess primary amines on
their surface that can be cross-linked with homobifunc-
tional agents such as glutaraldehyde (Figure 1). The
resulting interpeptide cross-links should stabilize con-
densed DNA from peptide dissociation and from metabo-
lism since it has been previously established that con-
densed DNA resists endonuclease attack.13,14
To establish that glutaraldehyde reacts with DNA
condensates to form interpeptide cross-links the time
course of the reaction was monitored indirectly using a
fluorescent intercalator dye. SYBR-Gold was selected since
its intercalation into DNA is not significantly inhibited in
sodium chloride up to 1 M. In the absence of sodium
Figure 2sKinetics of glutaraldehyde cross-linking CWK18 DNA condensates.
The reaction between glutaraldehyde and condensed DNA was measured
indirectly by a fluorescence assay described in Materials and Methods. An
inverse relationship between the amount of glutaraldehyde added and
fluorescence intensity indicated an increased reaction rate corresponding to
increased glutaraldehyde cross-linking. The data represents un-cross-linked
(9), 1 mol equiv (b), 2 mol equiv (2), 3 mol equiv ([), and 4 mol equiv (1)
cross-linked DNA condensates.
Figure 3sParticle size and ú potential analysis of cross-linked DNA
condensates. CWK18 DNA condensates cross-linked with 0−5 mol equiv of
glutaraldehyde exhibited particle sizes between 55 and 70 nm as shown in
panel A. At concentrations of 10 and 50 mol equiv of glutaraldehyde the particle
size increased by 1 and 2 orders of magnitude (panel A). Condensates
prepared at 0−4 mol equiv of glutaraldehyde had a ú potential between +34−
41 mV (panel B).
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chloride, the reaction of SYBR-Gold with CWK18 DNA
condensates produces minimal fluorescence whereas the
partial dissociation of condensates that occurred in 0.35
M sodium chloride produced a maximal fluorescence fol-
lowing intercalation (Figure 2). After the addition of
glutaraldehyde, the formation of interpeptide cross-links
stabilized CWK18 DNA condensates from dissociating in
0.35 M sodium chloride, leading to a decrease in the
fluorescence intensity as the reaction proceeded over 5 h
(Figure 2). Analysis of the reaction profile while varying
the stoichiometry of glutaraldehyde from 1 to 4 mol equiv
established a progressive decrease in fluorescence intensity
that approached reaction completion in 5 h, suggesting that
increasing the glutaraldehyde concentration leads to the
formation of additional cross-links and further stabilization
of DNA condensates (Figure 2).
Since glutaraldehyde could potentially also produce
interparticle cross-links leading to larger DNA condensates,
the relationship between the degree of cross-linking and
the particle size was investigated by QELS analysis. DNA
condensates prepared with 1 to 5 mol equiv of glutaralde-
hyde maintained a particle size of 55-70 nm, whereas
stoichiometries of 10 mol equiv or higher caused a signifi-
cant increase in size suggesting the formation of interpar-
ticle cross-links (Figure 3A). At 4 mol equiv of glutaralde-
hyde or lower, the ú potential of DNA condensates remained
between +34-41 mV, establishing minimal change in the
overall charge of DNA condensates (Figure 3B).
The shear stress stability of glutaraldehyde cross-linked
DNA condensates was evaluated by gel electrophoresis.
CWK18 DNA condensates resist fragmentation when sub-
jected to 30 s sonication until the sodium chloride concen-
tration reached 0.7 M or higher, causing dissociation of
peptide resulting in DNA fragmentation during sonication
(Figure 4A). By comparison, DNA condensates cross-linked
with 1 mol equiv of glutaraldehyde resist fragmentation
in 0.9 M sodium chloride (Figure 4B). Reaction with 2 mol
equiv of glutaraldehyde led to further stabilization result-
ing in condensates that resist fragmentation in 1.2 M
sodium chloride (Figure 4C). Increasing the cross-linking
to 3 and 4 mol equiv of glutaraldehyde resulted in DNA
condensates that were stable up to 1.5 M sodium chloride
(Figure 4D and 4E). Alternatively, polylysine1007 DNA
condensates were found to be less stable, undergoing
fragmentation during sonication in 1.5 M sodium chloride
(Figure 4F). These results suggest that the interpeptide
cross-links formed with 3 and 4 mol equiv of glutaraldehyde
extend the stability of CWK18 DNA condensates beyond
Figure 4sShear stress stability of cross-linked DNA condensates. The stability of cross-linked DNA condensates was measured by 30 s 100 W sonication in the
presence of increasing sodium chloride concentration as described in Methods and Methods. The electrophoretic analysis of CWK18 DNA condensates prepared
with 0 (A), 1 (B), 2 (C), 3 (D) and 4 (E) mol equiv of glutaraldehyde were compared to polylysine1007 DNA condensates (F). Lanes 1 through 8 contain 0, 0.1,
0.3, 0.5, 0.7, 0.9, 1.2, and 1.5 M sodium chloride. The dissociation of CWK18 from DNA occurs at 0.7 M sodium chloride (panel A, lane 5) as determined by the
formation of fragments during sonication. Alternatively, 1 mol equiv of glutaraldehyde extended the DNA stability to 0.9 M sodium chloride (panel B, lane 6), 2
mol equiv of glutaraldehyde increased the stability to 1.2 M sodium chloride (panel C, lane 7), and 3 and 4 mol equiv of glutaraldehyde resulted in DNA
condensates that were stable in 1.5 M sodium chloride (panels D and E). In contrast, polylysine1007 DNA condensates dissociate in 1.5 M sodium chloride (panel
F, lane 8). Each result was replicated twice.
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that achievable with a HMW polylysine. Control experi-
ments established that plasmid DNA did not change its
gel electrophoretic banding pattern when reacted with
glutaraldehyde, suggesting that the exocylic amines on
plasmid DNA bases are inexcessible to Schiff-base forma-
tion.
To be effective in gene delivery, cross-linked DNA
condensates should also resist digestion with serum endo-
nucleases. The metabolic stability of DNA was examined
by gel electrophoretic analysis of DNA condensates incu-
bated in mouse serum. Since un-cross-linked CWK18 DNA
condensates proved to be resistant to endogenous serum
endonuclease during a 24 h incubation, exogenous DNase
I was added to accelerate the metabolism into a 3 h time
period. Incubation of CWK18 DNA condensates in 50%
serum containing 0.12 units of DNase I resulted in me-
tabolism into oligonucleotides after 60 min (Figure 5A, lane
5). A trypsin contaminant produced a single strand nick
in the DNA, such that even at time zero only circular and
linear forms of DNA were recovered. Cross-linking CWK18
DNA condensates with 1-4 mol equiv of glutaraldehyde
produced a progressive increase in metabolic stability with
even 1 mol equiv of glutaraldehyde extending the stability
of DNA condensates from 60 to 90 min (Figure 5B). The
addition of 2 to 4 mol equiv extended the stability even
further as evidenced by an increase in band intensity at
90 to 180 min (Figure 5C-E). By comparison, polylysine1007
DNA condensates demonstrate improved serum stability
to that of glutaraldehyde cross-linking at 4 mol equiv
(Figure 5F).
The cytotoxicity of both free glutaraldehyde and cross-
linked DNA condensates were examined in cell culture. The
total protein of cell homogenates harvested 24 h after
transfecting cells in the presence of free glutaraldehyde or
cross-linked DNA condensates were indistinguishable from
control, indicating no toxicity when using 1-4 mol equiv
of glutaraldehyde corresponding to 1.5-6 µM.
The ability of cross-linked DNA condensates to release
DNA and mediate gene transfer was examined by measur-
ing the alkaline phosphatase secreted from HepG2 cells
over a 10-day period. When using chloroquine to augment
endosomal escape and increase gene expression, un-cross-
linked peptide DNA condensates produced a transient gene
expression profile that peaked around day 3-4 and then
decreased to near background by day 10 (Figure 6A), with
total transgene expression reaching 1.5 µg (Figure 6B). The
moderate increase in stability afforded by 1 mol equiv of
glutaraldehyde resulted in an expression profile and
cumulative SEAP production identical to that afforded by
un-cross-linked condensates. Alternatively, cross-linking
with 2 mol equiv of glutaraldehyde resulted in a peak
expression level that was nearly 2-fold greater than un-
cross-linked DNA condensates (Figure 6A). These results
are in contrast with those using 3 mol equiv of glutaral-
Figure 5sSerum stability of cross-linked condensates. The serum stability of DNA condensates cross-linked with 0 (A), 1 (B), 2 (C), 3 (D) and 4 (E) mol equiv
of glutaraldehyde are compared to polylysine1007 DNA condensates (F) using gel electrophoresis. Lanes 1 through 7 correspond to 0, 15, 30, 60, 90, 120, and
180 min digestion period. DNA stability was determined by observing a progressive decrease in the intensity of the circular and linear bands during the digestion,
ultimately leading to the disappearance of the bands. Metabolism was evident from a decrease in band intensity leading to the complete disappearance of bands
after 60 min for un-cross-linked DNA condensates (panel A, lane 4). DNA condensates prepared with 1 mol equiv of glutaraldehyde were delayed in metabolism
until 90 min (panel B, lane 5). DNA condensates prepared with 2, 3, and 4 mol equiv of glutaraldehyde were significantly more protected from metabolism during
the 180 min digestion, exhibiting only a decrease in the band intensity for circular and linear DNA (panels C−D, lanes 5−7). Polylysine1007 was better than
cross-linked condensates at protecting DNA throughout the 180 min digestion (panel F). Each results was replicated twice.
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dehyde which led to a 30% decrease in the maximal
expression level. Likewise, the maximal expression deter-
mined for 4 mol equiv cross-linked DNA condensate was
reduced by approximately 80% compared to CWK18 DNA
condensates.
Comparison of the cumulative SEAP production for each
condensate established a range of 0.3 to 2.2 µg over the
10-day period (Figure 6B). Un-cross-linked condensates and
cross-linked condensates possessing 1-3 mol equiv of
glutaraldehyde approached a plateau in total SEAP pro-
duction at day 6. The day 7-10 SEAP production for 2 and
3 mol equiv cross-linked DNA continued at a rate that was
2-fold greater than that of un-cross-linked or 1 mol equiv
cross-linked DNA condensates as determined by linear
regression of days 7-10. However, the SEAP production
mediated by CWK18 DNA condensates cross-linked with 4
mol equiv of glutaraldehyde was constant throughout day
1-10 resulting in a linear regression line with a slope of
42 ng/day and r2 ) 0.986 (Figure 6B).
When chloroquine was omitted from the assay, the
transient gene expression mediated by each peptide DNA
condensate was reduced by over 1 order of magnitude
(Figure 7A). As was also found for transfection in the
presence of chloroquine, the cumulative gene production
for 2 and 3 mol equiv cross-linked DNA condensates
produced day 7-10 slopes that were 2-fold greater than
un-cross-linked or 1 mol equiv cross-linked DNA conden-
sates (Figure 7B). In addition, the cumulative expression
for day 1-10 was linear (r2 ) 0.999) with a slope of 5.7
ng/day when using 4 mol equiv of glutaraldehyde to cross-
link DNA condensates, indicating a steady-state expression
of SEAP (Figure 7B).
A possible consequence of glutaraldehyde cross-linking
could be the formation of long polylysine chains. To confirm
that the expression profiles are not the result of linear
polymerization of CWK18 the transient gene expression
profile was studied using DNA condensates prepared with
a panel of HMW polylysines (Figure 8A). The expression
of SEAP exhibited a peak intensity correlating directly with
the increase in chain length of polylysine, with each peptide
DNA condensate mediating a maximum in the gene
expression at day 3-4 (Figure 8A). Dimeric CWK18 DNA
condensates produced approximately 10% more gene prod-
uct relative to CWK18 DNA condensates. Polylysine99
resulted in nearly 1.5-fold greater gene expression, whereas
the greatest levels of transient gene expression were
achieved with polylysine476 and 1007 DNA condensates which
produced 2.1 and 3.2-fold greater gene expression than
CWK18 DNA condensates (Figure 8B). Likewise, the cu-
mulative SEAP expression for days 7-10 also demon-
Figure 6sTransient gene expression profiles for cross-linked DNA condensates
in the presence of chloroquine. The 10-day HepG2 SEAP expression profiles
for cross-linked DNA condensates when including chloroquine in the
transfection are shown in panel A. The data represents the mean and standard
deviation when using un-cross-linked (9), 1 mol equiv (b), 2 mol equiv (2),
3 mol equiv ([), and 4 mol equiv (1) cross-linked DNA condensates. The
cumulative SEAP production for each DNA condensate is plotted in panel B.
The slope of the day 7−10 cumulative expression was 28.3 ng/mL 9, 26.8
ng/mL b, 52.8 ng/mL 2, and 52.9 ng/mL [ with r2 g 0.965 for each.
Figure 7sTransient gene expression profiles for cross-linked DNA condensates
in the absence of chloroquine. The 10-day HepG2 SEAP expression profile
mediated for cross-linked DNA condensates when omitting chloroquine from
the transfection are shown in panel A. The data represents the mean and
standard deviations when using un-cross-linked (9), 1 mol equiv (b), 2 mol
equiv (2), 3 mol equiv ([), and 4 mol equiv (1) cross-linked DNA
condensates. The cumulative SEAP production for each DNA condensate is
plotted in panel B. The slope of the day 7−10 cumulative expression was 3.3
ng/mL 9, 3.4 ng/mL b, 5.2 ng/mL 2, and 7.1 ng/mL [ with r2 g 0.996 for
each.
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strated a 3-fold increase in slope when comparing CWK18
DNA and polylysine1007 DNA condensates.
Discussion
The stability of a DNA formulation is fundamental to
its successful application in vivo since metabolism results
in the generation of fragmented DNA which no longer
mediates gene expression.14 Even though peptide DNA
condensates are more resistant to metabolism than naked
plasmid DNA11 or cationic lipid DNA condensates,10,23 the
in vitro stability determined by incubating condensates in
serum may not be predictive of the in vivo stability in which
the carrier molecules dissociate and are removed during
circulation. This is exemplified by earlier studies by Wu
and co-workers which showed the prolonged stability of
DNA condensates in vitro13 but a more limited stability in
vivo.24
Even though a short polylysine peptide of 20 amino acids
is sufficient to condense DNA into small condensates of
approximately 70 nm diameter, HMW polylysines38-1007
offer the advantage of binding to DNA with higher affinity,
resulting in a greater protection of DNA to metabolism.
However, there are also significant drawbacks in using
HMW polylysine to create carriers for gene delivery. The
polydispersity of HMW polylysine results in batch to batch
variation.25 The derivatization of HMW polylysine with
ligands or polyethlene glycol is achieved by random cou-
pling reactions which cannot control the conjugation site
along the polylysine chain creating further heterogeneity
in the carrier molecule.26-28 Perhaps most significant, is
the known cytotoxicity, complement activation, and inflam-
mation mediated by HMW polylysine.29 Given these limita-
tions we have focused our efforts on developing LMW DNA
carriers that are homogeneous, condense DNA into small
condensates, may be selectively derivatized, and are mini-
mal in size to reduce toxicity.
To overcome the limited stability afforded by LMW DNA
carriers, we propose to introduce interchain cross-links to
preformed DNA condensates to further improve their
stability. The advantage of this approach is the ability to
vary the degree of cross-linking to create condensates that
possess the required stability for different gene therapy
applications. Also, a variety of cross-linking agents could
potentially be used alone or in combination to create
controlled release of the DNA upon hydrolysis and dis-
sociation of the cross-linker and carrier. Control over these
events is a prerequisite to achieving delayed or prolonged
transgene expression.
The test of this hypothesis was conducted by attempting
to cross-link the surface amine groups on CWK18 DNA
condensates using glutaraldehyde. This cross-linker was
chosen because of its prior use in developing cross-linked
albumin microspheres for parenteral applications,20 its
safety record when used in a variety of prosthesis,30 and
the Schiff-base that forms is theoretically reversible.16,31
The results indicate that CWK18 DNA condensates undergo
cross-linking over a 4-5 h period when very low concentra-
tions of glutaraldehyde (1-4 mol equiv relative to CWK18)
are added. This amount of glutaraldehyde is far below the
amounts needed to observe toxicity in cells grown in
culture. Likewise, the maximum amount of glutaraldehyde
used (4 mol equiv) can theoretically cross-link 20% of the
amines present, assuming glutaraldehyde distributes equally
throughout the DNA condensates. At this low level, the
particle size is maintained, the ú potential of the DNA
condensates is unaffected, and trypsin can still be used to
enzymatically remove CWK18 to quantitatively release the
DNA. However, despite numerous attempts, we could not
demonstrate the spontaneous reversal of glutaraldehyde
cross-linked DNA condensates on prolonged dialysis in the
presence of protein.
One measure that establishes the relative stability of
peptide DNA condensates is the ability of DNA to resist
fragmentation during a 30 s 100 W sonication in a
dissociating concentration of sodium chloride. Cross-linked
DNA condensates were increasingly stable to sonicative
fragmentation at cross-linking levels ranging from 1 to 4
mol equiv of glutaraldehyde and were even found to be
more stable than HMW polylysine99-1007 DNA condensates.
This result suggests that interchain peptide cross-links,
and not linear polymerization of CWK18, are responsible
for the observed stabilization.
A similar correlation was observed from in vitro metabo-
lism studies that indicated that 4 mol equiv cross-linked
DNA condensates were significantly stabilized but still
inferior to polylysine1007 in their ability to protect DNA from
accelerated metabolism. Interestingly, DNA condensates
with and without cross-linking appeared to be directly
metabolized into fragments without going through the
linear form (Figure 5). This is in contrast to the catabolism
of naked DNA which is converted completely into linear
DNA prior to the formation of fragments.14 It is also evident
that intracellular proteolysis must somehow be involved
in the release of DNA from cross-linked condensates since
it less likely that the spontaneous reversal of Schiff-base
is the major route of DNA release prior to gene expression.
Clearly, the ability of cross-linked DNA condensates to
Figure 8sTransient gene expression profiles for HMW polylysine DNA
condensates. The 10-day HepG2 SEAP expression profiles are compared for
CWK18 (9), dimeric-CWK18 ([), polylysine99 (b), polylysine476 (1), and
polylysine1007 (2) DNA condensates when including chloroquine in the
transfection are shown in panel A. The cumulative SEAP production for each
DNA condensate is plotted in panel B. The slope of the day 7−10 cumulative
expression was 25.5 ng/mL 9, 32.7 ng/mL [, 74.7 ng/mL b, 103.7 ng/mL
1 and 109.3 ng/mL 2 with r2 g 0.978 for each.
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mediate gene expression is an important measure of their
ability to be useful in gene therapy applications. Since
cross-linking could delay the release of DNA inside cells,
it was important to study the transient gene expression
as opposed to a single 24 or 48 h expression level. However,
this was also technically challenging due to the doubling
rate of cells in culture which slows as they reach confluence.
At an optimal seeding density, cell cultures could be
maintained for 10 days, and the gene expression occurring
each day was determined using secreted alkaline phos-
phatase. The most significant effect of cross-linking DNA
condensates, in addition to stabilization to metabolism, was
an apparent flattening of the expression profile such that
4 mol equiv cross-linking of DNA condensates resulted in
a low level of steady-state expression over the 10-day
transfection which could not be extended in cell culture.
Omitting chloroquine more closely models in vivo condi-
tions and further confirmed that cross-linking could pro-
duce a steady-state rate of expression.
Analysis of the transient gene expression profile for
HMW polylysine38-1007 DNA condensates indicated a cor-
relation between the cummulative gene expression and the
degree of polymerization. We interpret these results as
partial validation of the hypothesis that increasing the
DNA condensate stability will result in greater gene
expression.
Future studies will examine the influence of cross-linking
to prolong the survival of DNA in vivo and to stabilized
DNA condensates prepared with more than one LMW
carrier to endow the delivery system with specific targeting.
The methods developed and used in this study have
established the principle of cross-linking DNA condensates
using glutaraldehyde and should allow testing of other
cross-linkers to stabilize peptide DNA condensates from
metabolism leading to prolonged gene expression in vivo.
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